anzutresgene autoleucel
Generic: Anzutresgene Autoleucel
anzutresgene autoleucel: 1 clinical trial tracked.
anzutresgene autoleucel evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anzutresgene autoleucel, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trials (1)
A Prospective, Multicenter, Open-label, Randomized, Actively Controlled, Parallel-group Phase 3 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of IMA203 Versus Investigator's Choice of Treatment in Patients With Previously Treated, Unresectable or Metastatic Cutaneous Melanoma (ACTengine® IMA203-301)
Primary endpoint: Progression-free survival assessed by BICR
InterventionalRandomizedopen360 targetStarted 2025-01Completion 2031-1050 sites · Canada, France, United StatesImmatics US, Inc.